Quince Therapeutics Inc (QNCX) Implied Volatility Current

Tracking QNCX implied volatility helps you identify when options premiums on Quince Therapeutics Inc are historically cheap or expensive, and where the best trades are hiding. Quince Therapeutics Inc implied volatility reflects the market's expectation of future price movement: when QNCX IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Quince Therapeutics Inc's implied volatility current levels in real time and filter for high-probability trades.

Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For QNCX, tracking metrics like QNCX IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on QNCX signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.

Quince Therapeutics, Inc., a biopharmaceutical company, focuses on advancing precision therapeutics for debilitating and rare diseases. The company has discovered a broad bone-targeting drug platform to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease. Its lead compound is NOV004, an anabolic peptide engineered to precisely target and concentrate at the bone fracture site The company was formerly known as Cortexyme, Inc. and changed its name to Quince Therapeutics, Inc. in August 2022. Quince Therapeutics, Inc. was incorporated in 2012 and is headquartered in South San Francisco, California.

Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where QNCX implied volatility sits today versus where it has been. Our scanner ranks Quince Therapeutics Inc implied volatility against its historical range, surfaces extremes in QNCX IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Quince Therapeutics Inc IV is rich or cheap — measure it, then act on it.